BitMEX Study Reveals Superior Performance of Perpetual Swap Listings, with an Average Price Gain of 62.55%, Outperforming Competitors
Notified -
Globe Newswire7-04-2025, 20:02
Junshi Biosciences Announces Toripalimab in Combination with Chemotherapy for Treatment of Advanced Triple-negative Breast Cancer Met Primary Endpoint in Phase 3 Clinical Study 21-02-2023, 10:53